KOBOBIO (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE updates on securities under Insolvency and Bankruptcy Code (IBC) surveillance framework with changes effective December 01, 2025. … | |||||||||||||||
BSE updates on securities under Insolvency and Bankruptcy Code (IBC) surveillance framework with changes effective December 01, 2025. Includes movement of 12 securities to Stage 0 and exclusion of 1 security from ASM.
| |||||||||||||||
BSE updates Additional Surveillance Measure for companies under Insolvency and Bankruptcy Code (IBC), with 12 securities moving to Stage 0 … | |||||||||||||||
BSE updates Additional Surveillance Measure for companies under Insolvency and Bankruptcy Code (IBC), with 12 securities moving to Stage 0 and 1 security being excluded from ASM effective December 01, 2025.
| |||||||||||||||
BSE updates surveillance measures for companies under Insolvency and Bankruptcy Code (IBC), with Kobo Biotech Ltd moving to Stage 1 … | |||||||||||||||
BSE updates surveillance measures for companies under Insolvency and Bankruptcy Code (IBC), with Kobo Biotech Ltd moving to Stage 1 surveillance effective October 30, 2025.
| |||||||||||||||